SUMMARY Activated partial thromboplastin times (APTT) for monitoring heparin therapy for venous thromboembolism tended to be inappropriately short if blood was collected in commercially available evacuated glass tubes. Five types of evacuated tubes marketed under the trade names Vacutainer and Venoject were examined. The APTT of heparinised blood collected in these tubes correlated poorly (r = 004 to r = 0 25) with that of blood samples from the same patients collected in plastic tubes. Most of the evacuated tube APTT were shorter than that of blood collected in plastic or siliconised glass tubes, but the results were unpredictable and varied from tube to tube and from batch to batch. This effect on heparin is apparently due to an unidentified substance which is eluted from the rubber stoppers of the tubes. Heparin control according to the APTT blood collected in these evacuated tubes is hazardous.
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Evacuated glass tubes are used extensively for the collection of blood specimens for haematological, biochemical, and other analyses; some of these tubes, containing liquid citrate, are labelled 'for coagulation purposes'. We noticed that activated partial thromboplastin times (APTT) for monitoring heparin therapy tended to be inappropriately short if blood was collected in these evacuated tubes.
Material and methods

SILICONISED GLASS TUBES
Glass-stoppered 10 ml glass tubes (Quickfit) were cleaned for 48 hours in dichromate-sulphuric acid, washed repeatedly with distilled water, and siliconised by rinsing twice with Repelcote (Hopkin and Williams). These will be referred to as ' 
HOMOGENISATION OF RUBBER ST9OPPERS
The stopper was cut into 2-3 mm fragments which were placed into 10 ml laboratory citrate and homogenised for 10 minutes at 40C with an Edmund Bihler blender. The homogenate was centrifuged at 3000g for 15 minutes, and the clear supernatant stopper extract was removed for use.
Results
HEPARIN CONCENTRATION-APTT RESPONSE
CURVE
Blood from the same donor was collected in reference glass tubes and in different makes of evacuated tubes, and PPP was prepared. Heparin was added in final concentrations varying from 0 05 to 0-8 IU/ml PPP, and the APTJ was determined. Heparin concentration-APTT response curves were constructed ( Fig. 1 ). The blood collected in siliconised tubes had a sigmoid concentration-response curve, APTT showing sensitivity to as little as 0 05 IU/ml heparin/ml plasma. Similar curves constructed with blood collected in evacuated tubes were relatively flat and showed no or slight prolongation of the APTI with increasing heparin concentrations.
APTT ON BLOOD COLLECTED IN EVACUATED GLASS TUBES AND POLYSTYRENE TUBES
Blood specimens were collected in duplicate from patients receiving heparin for the treatment of venous thromboembolism, myocardial infarction, or the prevention of venous thrombosis. The patients received an initial intravenous bolus dose of 5000 IU of heparin followed by a maintenance dose of approximately 24000 IU/24 hours, given by continuous intravenous infusion. The results are given in Table 3 . The mean APTT of the reference method varied from 113 to 245 seconds. The mean APTT of the VacBlu specimens was significantly (P < 0 001, Student t test for independent means) longer, that of the VacBla also significantly (P < 0 001) longer; that of the VenBlu was significantly (P < 0 001) shorter and that of the VenBla significantly (P < 0 001) longer than their corresponding control reference APTT. The citrate of the evacuated tubes thus had an adverse influence on the APTT of heparinised plasma. The effect varied and resulted in either a shortening or prolongation of the APTT.
INFLUENCE OF RUBBER STOPPER EXTRACT ON HEPARIN-APTT RESPONSE
Blood from one donor was used in each set of these experiments, each with its own control. Blood was obtained in a polystyrene syringe and transferred to (a) reference siliconised tubes with laboratory citrate, and (b) siliconised tubes containing citrate with rubber stopper extract from a specific type of evacuated tube. Heparin 0-5 IU/ml whole blood was added. In each instance 10 tubes were used and the mean (± 1 SD) APTT was determined.
The results are given in Table 3 . In all instances the mean APTT of heparinised blood added to citrate containing a rubber stopper extract was significantly (P < 0-001; Student t test for independent means) shorter than that of the reference method. The mean APTT of blood anticoagulated with stopper extract was also significantly (P < 0 001) shorter than that of blood collected in citrate obtained from the same batches of VacBla and VenBla. With the VenBlu tube the mean APTT of blood collected in evacuated tube citrate as well as of that collected in a stopper extract were both significantly (P < 0 001) shorter than that of the reference method.
Discussion
Heparin is the drug of choice in the treatment of patients with venous thromboembolic disease. The effect of heparin on the coagulation mechanism classically has been monitored with the whole blood clotting time, but in recent years the APTT has been regarded as more accurate and convenient.1-4 In a prospective study, it was shown that recurrence of Table 3 APTT on blood specimens collected in tubes containing citrate from evacuated tubes, and in tubes containing an extract from evacuated tube rubber stoppers (mean + I SD; n = 10) (Fig. 1) .
Other APTT were unpredictable and varied from batch to batch and from tube to tube within the same batch; they also varied from subject to subject if tubes from the same and different batches were used (Table 2) . Presumably a contaminant is present in the evacuated tubes. The substance is present in the citrate in the evacuated tubes, and it can be extracted from their rubber stoppers (Table 3) ; it appears to neutralise heparin (Fig. 1) 
